H. Suzuki et al., ENCAPSULATION OF VIP INTO LIPOSOMES RESTORES VASORELAXATION IN HYPERTENSION IN-SITU, American journal of physiology. Heart and circulatory physiology, 40(1), 1996, pp. 282-287
The purpose of this study was to determine whether vasoactive intestin
al peptide (VIP) elicits vasodilation in the in situ peripheral microc
irculation of hamsters with spontaneous hypertension and whether encap
sulation of VIP into liposomes modulates this response. Using intravit
al microscopy, we found that suffusion of VIP (0.05 and 0.1 nmol) alon
e over cheek pouch resistance arterioles of normotensive hamsters elic
ited significant vasodilation that was potentiated and prolonged by en
capsulation of the peptide into liposomes (P < 0.05). By contrast, VIP
(0.5 and 0.1 nmol) had no significant effects on arteriolar diameter
in hamsters with spontaneous hypertension. However, encapsulation of V
IP into liposomes restored its vasorelaxant effects in hypertensive an
imals, although the duration of vasodilation was significantly shorter
in comparison with controls (P < 0.05). Empty liposomes had no signif
icant effects on arteriolar diameter in either group. These data indic
ate that VIP-induced vasodilation in the peripheral microcirculation i
n situ is impaired in essential hypertension and that encapsulation of
VIP into liposomes restores, in part, this response.